Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 122
- Videos
FoxNRTH’s Principal Chris Murray On Why A ‘Systems Approach’ Is Vital For Cannabis Businesses Development
While many in the industry continue to extol the commercial opportunities of the cannabis industry in order to try and turn the dial on government and institutional support, FoxNRTH’s Principal Chris Murray believes in a different approach.
- Companies
Astrasana and Clever Leaves Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves”), a global medicinal cannabis company, announced today the arrival of their first shipment of medical cannabis extracts from Colombia to Switzerland-based partner, Astrasana Holding AG (“Astrasana”).
- Adult-Use
Unpaid cannabis tax in Canada balloons to almost CA$200 million
Unpaid cannabis tax in Canada balloons to almost CA$200 million Federally licensed cannabis producers owed the Canada Revenue Agency 192.7 million Canadian dollars ($145 million) as of March 31, 2023, a more than threefold increase over the 2021-22 fiscal year’s CA$52.4 million, reports MJ Biz Daily.
- Press releases
Stenocare To Launch Medical Cannabis Oils In Germany In Coming Months
The new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for prescription-based sales to German patients.
- Uncategorized
Stenocare bringt in den kommenden Monaten medizinische Cannabisöle in Deutschland auf den Markt
Das neue medizinische Cannabisöl von Stenocare hat vom Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) die Zulassung für den rezeptpflichtigen Verkauf an deutsche Patienten erhalten.
- Companies
Fewer research analysts covering cannabis underscores industry woes
Fewer research analysts covering cannabis underscores industry woes Fewer research analysts are covering the U.S. cannabis industry, reports MJ Biz Daily.
- Markets & Stocks
Chill Brands Sees Stock Climb 80% On New UK Supply Deal, IM Cannabis Reduces Losses, & Celadon Signs First Supply Contract
Chill Brands Group [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CHLL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Chill Brands’ stock value has nearly doubled over the last week following the announcement of a new sales and distribution partnership in the UK.
- Press releases
EUCannaJobs Announces Launch Of New Website
The cannabis industry is one of the fastest-growing industries in Europe and there are now many different types of jobs available in this sector.
- Events
International Cannabis Business Conference (ICBC) To Return To Berlin In June 2023
The International Cannabis Business Conference is once again bringing its flagship business-to- business (B2B) event and tradeshow back to Berlin, Germany on June 29-30th, 2023.
- Opinion
‘Enabling Medical Cannabis To Grow Properly In Europe Is The Real Opportunity’ – Avicanna
In the run-up to Cannabis Europa 2023, Prohibition Partners’ CEO Stephen Murphy caught up with Aras Azadian, co-founder and CEO of Avicanna. Stephen and Aras discuss Avicanna’s landmark partnership with Canadian pharmacy giant Shoppers Drug Mart, alongside reviewing differences between the Canadian and European industries, patient access and affordability and what to look forward to in the emerging European market.
- Markets & Stocks
OCT Secures MHRA Approval For Clinical Trials, Cantourage Posts First Profits, & More From DanCann Pharma
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”OCTP.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] The London Stock Exchange listed pharmaceutical cannabis company announced yesterday that it has at last secured MHRA approval for its Phase 1 Clinical Trials for its lead compound.
- Policy & Regulation
France Becomes Latest European Country To Move To Ban HHC As ‘Legal’ Cannabis Alternative Continues Rapid Spread
FRANCE is set to become the latest European country to ban the increasingly prevalent semi-synthetic cannabinoid and ‘legal high’ hexahydrocannabinol, better known as HHC.









